320 related articles for article (PubMed ID: 21995486)
1. Hypothalamic-pituitary-adrenal axis suppression related to topical glucocorticoid therapy in a child with psoriatic exfoliative erythroderma.
Campbell LS; Chevalier M; Levy RA; Rhodes A
Pediatr Dermatol; 2012; 29(1):101-4. PubMed ID: 21995486
[TBL] [Abstract][Full Text] [Related]
2. Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults.
Gulliver T; Eid N
Immunol Allergy Clin North Am; 2005 Aug; 25(3):541-55, vii. PubMed ID: 16054542
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic-pituitary-adrenal function in children with asthma and rhinitis treated with topical glucocorticosteroids.
Wolthers OD; Honour JW
Clin Exp Allergy; 1998 May; 28(5):545-50. PubMed ID: 9645590
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the HPA axis in pediatric patients with atopic dermatitis.
Ishay A; Ziv M; Kerner M; Luboshitzky R
Arch Dermatol; 2007 Nov; 143(11):1449-50. PubMed ID: 18025377
[No Abstract] [Full Text] [Related]
5. [The unsuitability of using corticosteroid preparations in the treatment of psoriasis in children].
Grishko TN
Vestn Dermatol Venerol; 1989; (9):69-71. PubMed ID: 2532822
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamic-pituitary-adrenal axis suppression in systemic glucocorticoid-treated infantile hemangiomas: putting the risk into context.
Sidbury R
Arch Dermatol; 2009 Mar; 145(3):319-20. PubMed ID: 19289767
[No Abstract] [Full Text] [Related]
7. Guidelines for using superpotent topical steroids.
Prawer SE; Katz HI
Am Fam Physician; 1990 May; 41(5):1531-8. PubMed ID: 2333829
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic doses of glucocorticoids: implications for oral medicine.
Baid SK; Nieman LK
Oral Dis; 2006 Sep; 12(5):436-42. PubMed ID: 16910913
[TBL] [Abstract][Full Text] [Related]
9. Adrenal insufficiency after glucocorticoid withdrawal in children with rheumatic diseases.
Huber BM; Bolt IB; Sauvain MJ; Flück CE
Acta Paediatr; 2010 Dec; 99(12):1889-93. PubMed ID: 20649769
[TBL] [Abstract][Full Text] [Related]
10. Psoriatic erythroderma and bullous pemphigoid treated successfully with acitretin and azathioprine.
Roeder C; Driesch PV
Eur J Dermatol; 1999; 9(7):537-9. PubMed ID: 10523731
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
[TBL] [Abstract][Full Text] [Related]
12. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
Coureau B; Bussières JF; Tremblay S
Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of iatrogenic Cushing syndrome: questions of glucocorticoid withdrawal].
Igaz P; Rácz K; Tóth M; Gláz E; Tulassay Z
Orv Hetil; 2007 Feb; 148(5):195-202. PubMed ID: 17344139
[TBL] [Abstract][Full Text] [Related]
14. Impaired recovery of hypothalamic-pituitary-adrenal axis function and hypoglycemic seizures after high-dose inhaled corticosteroid therapy in a toddler.
Kennedy MJ; Carpenter JM; Lozano RA; Castile RG
Ann Allergy Asthma Immunol; 2002 May; 88(5):523-6. PubMed ID: 12027076
[TBL] [Abstract][Full Text] [Related]
15. [Glucocorticoid treatments and adrenal function].
Guignat L; de Bucy C; Bertherat J
Rev Prat; 2008 May; 58(9):966-70. PubMed ID: 18672662
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of the hypothalamic-hypophyseal-adrenal axis in patients with chronic obstructive lung disease. Comparison of inhalant with systemic glucocorticoid therapy].
Santen RT; Schlaghecke R; Schwalen A
Dtsch Med Wochenschr; 1997 Apr; 122(16):497-503. PubMed ID: 9162622
[TBL] [Abstract][Full Text] [Related]
17. Advances in glucocorticoid therapy.
Baxter JD
Adv Intern Med; 2000; 45():317-49. PubMed ID: 10635054
[No Abstract] [Full Text] [Related]
18. The hypothalamic-pituitary-adrenal axis in asthmatic children.
Priftis KN; Papadimitriou A; Nicolaidou P; Chrousos GP
Trends Endocrinol Metab; 2008 Jan; 19(1):32-8. PubMed ID: 18155557
[TBL] [Abstract][Full Text] [Related]
19. [Control of the hypothalamic-hypophyseal-adrenal cortex regulatory zone with ACTH and the metopirone test in long-term glucocorticoid therapy].
Saitmacher F
Dtsch Gesundheitsw; 1970 Dec; 25(49):2334-8. PubMed ID: 4324036
[No Abstract] [Full Text] [Related]
20. Topical glucocorticoids: what has been achieved? What is still to be done?
Schäfer-Korting M
Curr Probl Dermatol; 1993; 21():192-201. PubMed ID: 8299373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
